Cerebral small vessel disease marker validated for wider use in dementia trials

A new neuroimaging marker of cerebral small vessel disease is related to general cognition and may serve to identify persons at risk of dementia in future clinical trials, a landmark study has found.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup